Swiss pharmaceutical company Roche has announced a major investment of $50 billion in the United States in the next five years. This move is expected to create 12,000 new jobs and will focus on expanding manufacturing, distribution, and research facilities. The decision comes in the wake of a similar investment by another Swiss pharmaceutical giant, Novartis. Roche’s investment aims to bolster its presence in the US market and further support innovation in the development of medicines and diagnostics. The company’s commitment to creating thousands of new jobs highlights its dedication to contributing to the economic growth and development of the United States. This significant investment signals Roche’s confidence in the US economy and its potential for growth in the pharmaceutical and healthcare sectors.